Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 7746 | 9.1 |
09:34 ET | 16503 | 8.98 |
09:36 ET | 8010 | 8.945 |
09:38 ET | 4922 | 8.925 |
09:39 ET | 2100 | 8.98 |
09:41 ET | 922 | 9.025 |
09:43 ET | 3606 | 9.05 |
09:45 ET | 2949 | 9.05 |
09:48 ET | 9636 | 9.0301 |
09:50 ET | 1835 | 9.06 |
09:52 ET | 912 | 9.075 |
09:54 ET | 4075 | 9.02 |
09:56 ET | 4647 | 9.01 |
09:57 ET | 749 | 9.02 |
09:59 ET | 100 | 9.02 |
10:01 ET | 1560 | 9.02 |
10:03 ET | 589 | 8.99 |
10:06 ET | 7076 | 8.985 |
10:08 ET | 678 | 8.98 |
10:10 ET | 5293 | 8.989 |
10:12 ET | 19831 | 9.05 |
10:14 ET | 913 | 9.03 |
10:15 ET | 1832 | 9.03 |
10:17 ET | 300 | 9.03 |
10:19 ET | 1989 | 9.0658 |
10:21 ET | 4868 | 9.1 |
10:24 ET | 100 | 9.115 |
10:26 ET | 7276 | 9.12 |
10:28 ET | 3758 | 9.08 |
10:30 ET | 1840 | 9.035 |
10:32 ET | 1956 | 9.056 |
10:33 ET | 3239 | 9.04 |
10:35 ET | 739 | 9.035 |
10:37 ET | 1480 | 9.02 |
10:39 ET | 1100 | 9 |
10:42 ET | 1434 | 9 |
10:44 ET | 19965 | 8.96 |
10:46 ET | 5133 | 8.975 |
10:48 ET | 100 | 8.97 |
10:50 ET | 2566 | 8.94 |
10:51 ET | 8036 | 8.95 |
10:53 ET | 4611 | 8.96 |
10:55 ET | 4079 | 8.955 |
10:57 ET | 1554 | 8.95 |
11:00 ET | 522 | 8.94 |
11:02 ET | 10639 | 8.94 |
11:04 ET | 1189 | 8.97 |
11:06 ET | 503 | 8.98 |
11:08 ET | 3606 | 8.99 |
11:09 ET | 5541 | 8.96 |
11:11 ET | 4056 | 8.96 |
11:13 ET | 561 | 8.97 |
11:15 ET | 2552 | 8.97 |
11:18 ET | 980 | 8.96 |
11:20 ET | 431 | 8.95 |
11:22 ET | 2941 | 8.9585 |
11:24 ET | 435 | 8.95 |
11:26 ET | 1605 | 8.95 |
11:27 ET | 335 | 8.95 |
11:29 ET | 673 | 8.94 |
11:31 ET | 200 | 8.93 |
11:33 ET | 2199 | 8.948 |
11:36 ET | 5083 | 8.94 |
11:38 ET | 616 | 8.94 |
11:40 ET | 1242 | 8.945 |
11:42 ET | 758 | 8.98 |
11:44 ET | 4876 | 8.96 |
11:45 ET | 2563 | 8.94 |
11:47 ET | 5699 | 8.94 |
11:49 ET | 488 | 8.9496 |
11:51 ET | 1411 | 8.96 |
11:54 ET | 200 | 8.97 |
11:56 ET | 2243 | 8.95 |
12:00 ET | 16468 | 8.98 |
12:02 ET | 806 | 8.97 |
12:03 ET | 10105 | 9 |
12:05 ET | 4904 | 8.98 |
12:07 ET | 7746 | 8.98 |
12:09 ET | 1296 | 8.97 |
12:12 ET | 14293 | 8.97 |
12:14 ET | 2998 | 8.97 |
12:16 ET | 587 | 8.975 |
12:18 ET | 3153 | 8.985 |
12:20 ET | 3376 | 9.01 |
12:21 ET | 7425 | 9.06 |
12:23 ET | 3513 | 9.12 |
12:25 ET | 6071 | 9.135 |
12:27 ET | 1700 | 9.14 |
12:30 ET | 2473 | 9.13 |
12:32 ET | 1558 | 9.12 |
12:34 ET | 3216 | 9.1294 |
12:36 ET | 1250 | 9.11 |
12:38 ET | 1227 | 9.08 |
12:39 ET | 1114 | 9.06 |
12:41 ET | 249 | 9.06 |
12:43 ET | 5165 | 9.04 |
12:45 ET | 2160 | 9.01 |
12:48 ET | 2154 | 8.995 |
12:50 ET | 4084 | 9.035 |
12:52 ET | 1106 | 9.03 |
12:54 ET | 100 | 9.03 |
12:56 ET | 2410 | 9.015 |
12:57 ET | 433 | 9.01 |
12:59 ET | 706 | 9.01 |
01:01 ET | 2315 | 9.0075 |
01:03 ET | 100 | 9.01 |
01:08 ET | 4845 | 9.02 |
01:10 ET | 4859 | 9.01 |
01:12 ET | 304 | 9.005 |
01:14 ET | 1360 | 9.0075 |
01:15 ET | 2590 | 8.99 |
01:17 ET | 1082 | 8.975 |
01:19 ET | 3668 | 8.985 |
01:21 ET | 400 | 8.99 |
01:24 ET | 1656 | 8.99 |
01:26 ET | 469 | 8.99 |
01:28 ET | 1200 | 8.975 |
01:32 ET | 325 | 8.98 |
01:33 ET | 3473 | 8.985 |
01:35 ET | 1666 | 9 |
01:39 ET | 1201 | 9.01 |
01:42 ET | 1413 | 8.99 |
01:44 ET | 133 | 9 |
01:46 ET | 322 | 8.995 |
01:48 ET | 1483 | 8.98 |
01:50 ET | 2340 | 8.9799 |
01:51 ET | 3546 | 8.97 |
01:53 ET | 1419 | 8.95 |
01:55 ET | 1255 | 8.95 |
01:57 ET | 258 | 8.955 |
02:00 ET | 297 | 8.951 |
02:02 ET | 5665 | 8.96 |
02:06 ET | 859 | 8.965 |
02:08 ET | 400 | 8.97 |
02:09 ET | 1609 | 8.99 |
02:11 ET | 644 | 9 |
02:13 ET | 200 | 9 |
02:15 ET | 578 | 9 |
02:18 ET | 11407 | 9.03 |
02:20 ET | 100 | 9.03 |
02:22 ET | 3135 | 9.03 |
02:24 ET | 1560 | 9.02 |
02:26 ET | 644 | 9.02 |
02:27 ET | 31407 | 9.08 |
02:29 ET | 1205 | 9.08 |
02:31 ET | 253 | 9.08 |
02:33 ET | 400 | 9.07 |
02:36 ET | 1357 | 9.07 |
02:38 ET | 1945 | 9.07 |
02:40 ET | 1421 | 9.06 |
02:42 ET | 931 | 9.055 |
02:44 ET | 2486 | 9.05 |
02:45 ET | 543 | 9.05 |
02:47 ET | 1654 | 9.05 |
02:49 ET | 1028 | 9.0463 |
02:51 ET | 1535 | 9.05 |
02:54 ET | 2146 | 9.05 |
02:56 ET | 5065 | 9.08 |
02:58 ET | 1940 | 9.06 |
03:00 ET | 1320 | 9.08 |
03:02 ET | 1557 | 9.05 |
03:03 ET | 2407 | 9.01 |
03:05 ET | 315 | 9.02 |
03:07 ET | 500 | 9.03 |
03:09 ET | 816 | 9.025 |
03:12 ET | 3233 | 9.01 |
03:14 ET | 2271 | 9 |
03:16 ET | 435 | 9.005 |
03:18 ET | 6300 | 9 |
03:20 ET | 1926 | 9 |
03:21 ET | 100 | 9 |
03:23 ET | 1577 | 8.99 |
03:25 ET | 2531 | 8.995 |
03:27 ET | 4667 | 8.985 |
03:30 ET | 1486 | 8.985 |
03:32 ET | 4326 | 8.98 |
03:34 ET | 2386 | 8.99 |
03:36 ET | 7313 | 9.01 |
03:38 ET | 1841 | 8.985 |
03:39 ET | 3630 | 8.95 |
03:41 ET | 5429 | 8.98 |
03:43 ET | 975 | 8.975 |
03:45 ET | 1113 | 8.97 |
03:48 ET | 1178 | 8.975 |
03:50 ET | 5676 | 9.02 |
03:52 ET | 10866 | 9.035 |
03:54 ET | 9117 | 8.99 |
03:56 ET | 11509 | 8.965 |
03:57 ET | 15469 | 8.93 |
03:59 ET | 25836 | 8.95 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -2.2x | --- |
Prothena Corporation PLC | 1.1B | -6.0x | --- |
Immatics NV | 1.3B | -12.0x | --- |
Nurix Therapeutics Inc | 906.8M | -7.0x | --- |
Silence Therapeutics PLC | 886.5M | -16.7x | --- |
Arcus Biosciences Inc | 1.5B | -5.2x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 15.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.